Matches in Nanopublications for { ?s ?p "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP978391.RATHeYx9SJkyOMJkvtS_BydwxwvWFiRHLLbuL93wy3Pv0130_assertion description "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978391.RATHeYx9SJkyOMJkvtS_BydwxwvWFiRHLLbuL93wy3Pv0130_provenance.
- assertion description "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1143096.RAhNWzLdcyzkxftJ-X13oX_5KEnhagbHTNC2haeCMdNms130_assertion description "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1143096.RAhNWzLdcyzkxftJ-X13oX_5KEnhagbHTNC2haeCMdNms130_provenance.
- NP1143094.RA7Q6pp6HxdVLmCWTzABZfVktb983a4kFV-lkYjw4gHW0130_assertion description "[The current study identifies 'CALR(-)ASXL1(+)' and 'triple-negative' as high-risk molecular signatures in PMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1143094.RA7Q6pp6HxdVLmCWTzABZfVktb983a4kFV-lkYjw4gHW0130_provenance.